Evidence map›Paper›PMID 28786087›Full record

ArticleClinical orthopaedics and related research2017

What Should Define Preoperative Anemia in Primary THA?

Mitchell R Klement, Ashwin Peres-Da-Silva, Brian T Nickel, Cynthia L Green, Samuel S Wellman, David E Attarian, Michael P Bolognesi, Thorsten M Seyler

Open access · bronzeAbstract read
In one paragraph

Article in Clinical orthopaedics and related research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mitchell R KlementDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA. mitchell.klement@dm.duke.edu.
Ashwin Peres-Da-SilvaDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA.
Brian T NickelDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA.
Cynthia L GreenDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Samuel S WellmanDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA.
David E AttarianDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA.
Michael P BolognesiDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA.
Thorsten M SeylerDepartment of Orthopedics, Duke University Medical Center, Box 3000, Durham, NC, 27710, USA.
Duke Medical Center · USDuke University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of tranexamic acid (TXA) in THA decreases the risk of transfusion after surgery. However, nearly 10% of patients still undergo a transfusion, which has been independently associated with an increased risk of complications. Preoperative anemia has been proven to be a strong predictor of transfusion after THA, but the ideal "cutoff" values in today's population that maximize sensitivity and specificity to predict transfusion have yet to be established. QUESTIONS/PURPOSES: (1) Which preoperative factors are associated with postoperative transfusion in the setting of TXA use? (2) If preoperative hemoglobin (Hgb) remains associated with transfusion, what are the best-supported preoperative Hgb cutoff values associated with increased transfusion after THA?

methodsA retrospective chart analysis was performed from January 1, 2013, to January 1, 2015, on 558 primary THAs that met prespecified inclusion criteria. A multivariable logistic regression analysis model was used to identify independent factors associated with transfusion. Area under the receiver-operator curve (AUC) was used to determine the best-supported preoperative Hgb cut point across all participants, as well as adjusted by sex and TXA use. Overall, 60 patients with a blood transfusion were included and compared with 498 control subjects (11% risk of transfusion).

resultsAfter controlling for potential confounding variables such as age, sex, American Society of Anesthesiologist score, intravenous TXA (IV TXA) use, and preoperative Hgb, we found that patients with lower preoperative Hgb (g/dL per 1-unit decrease, odds ratio [OR], 2.6; 95% CI, 2.0-3.5; p < 0.001), female sex (vs male, OR, 4.2; 95% CI, 1.7-10.3; p = 0.002), and those unable to receive IV TXA (topical TXA/no TXA, OR, 13.5; 95% CI, 6.3-28.6; p < 0.001) were more likely to receive a transfusion. Of these, preoperative Hgb was found to be the variable most highly associated with transfusion (AUC, 0.876). A preoperative Hgb cutoff value of 12.6 g/dL maximized the AUC (0.876) for predicting transfusion across all patients unadjusted for baseline characteristics (sensitivity = 83, specificity = 84) with values of 12.5 g/dL (sensitivity = 85, specificity = 77) and 13.5 g/dL (sensitivity = 92, specificity = 77) for women and men, respectively.

conclusionsThe 1968 WHO definitions of anemia (preoperative Hgb < 13 g/dL for men and < 12 g/dL for women) used currently may underestimate patients at risk of transfusion after THA today. Further studies are needed to see if blood conservation referral decreases the risk of transfusion with preoperative treatment of anemia. LEVEL OF EVIDENCE: Level III, therapeutic study.

Indexed as

Arthroplasty, Replacement, KneeAnemiaAntifibrinolytic AgentsBiomarkersBlood Loss, SurgicalBlood TransfusionChi-Square DistributionFemaleHemoglobinsHumansKnee JointLogistic ModelsMaleMultivariate AnalysisOdds RatioPostoperative HemorrhageAntifibrinolytic AgentsBiomarkersHemoglobinsTranexamic Acid

Identifiers

PMID28786087
PMCPMC5638743
OpenAlexW2744217813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.